Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. Reply
- PMID: 36198187
- DOI: 10.1056/NEJMc2210918
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. Reply
Comment on
-
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.N Engl J Med. 2022 Oct 6;387(14):1336. doi: 10.1056/NEJMc2210918. N Engl J Med. 2022. PMID: 36198186 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources